A 3-day estrogen treatment improves prefrontal cortex-dependent cognitive function in postmenopausal women

被引:63
|
作者
Krug, Rosemarie [1 ]
Born, Jan [1 ]
Rasch, Bjoern [1 ]
机构
[1] Med Univ Lubeck, Dept Neuroendocrinol, D-23538 Lubeck, Germany
关键词
estrogen; cognitive functions; working memory; verbal memory; postmenopausal women; short-term administration;
D O I
10.1016/j.psyneuen.2006.05.007
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Estrogen secretion in young women follows a cyclic pattern characterized by a pronounced surge in estrogen around ovulation. The way in which this estrogen peak affects cognitive functioning is unclear. Short-term estrogen treatment for a few days mimicking normal pre-menopausal estrogen dynamics substantially enhanced cognitive functions in ovariectomized animals. Here, we provide evidence that inducing a single estrogen peak in postmenopausal women improves their cognitive abilities. Healthy women (51-64yrs, n = 14) received either 100 mu g estrogen transdermally for 3 days or placebo in a double-blind within-subject design. The treatment caused a temporary rise in serum estrogen levels roughly comparable to the mid-cyclic changes in estrogen in young women. At the end of the treatment, the women completed two types of tests involving primarily hippocampus-dependent functions of memory retention or prefrontal cortex-dependent functions. Results revealed a clear beneficial effect of estrogen on tasks mainly involving the prefrontal cortex: performance on a digit-ordering task (p < 0.05) and on a task requiring short-term memory of event sequences in an unfamiliar story (p < 0.01) were improved, and susceptibility to interference in the Stroop test (p < 0.05) was diminished after estrogen. On the other hand, estrogen did not affect hippocampus-dependent retention of a story, with delayed recall tested after 30 min or 1 week, although immediate recall was improved by estrogen. We conclude that in postmenopausal women, a transient increase in plasma estrogen concentration acutely improves prefrontal cortex-dependent cognitive functions, whereas hippocampus-dependent memory retention is Less affected. Our results encourage future studies to investigate whether repeated induction of short-lasting estrogen peaks could enhance cognitive efficacy of hormonal replacement therapy. (c) 2006 Elsevier Ltd. All rights reserved.
引用
收藏
页码:965 / 975
页数:11
相关论文
共 50 条
  • [31] Effect of Anticholinergic Use for the Treatment of Overactive Bladder on Cognitive Function in Postmenopausal Women
    Geller, Elizabeth J.
    Crane, Andrea K.
    Wells, Ellen C.
    Robinson, Barbara L.
    Jannelli, Mary L.
    Khandelwal, Christine M.
    Connolly, AnnaMarie
    Parnell, Brent A.
    Matthews, Catherine A.
    Dumond, Julie B.
    Busby-Whitehead, Jan
    CLINICAL DRUG INVESTIGATION, 2012, 32 (10) : 697 - 705
  • [32] Effect of Anticholinergic Use for the Treatment of Overactive Bladder on Cognitive Function in Postmenopausal Women
    Elizabeth J. Geller
    Andrea K. Crane
    Ellen C. Wells
    Barbara L. Robinson
    Mary L. Jannelli
    Christine M. Khandelwa
    Anna Marie Connolly
    Brent A. Parnell
    Catherine A. Matthews
    Julie B. Dumond
    Jan Busby-Whitehead
    Clinical Drug Investigation, 2012, 32 : 697 - 705
  • [33] Meta-analyses of the effect of hormone treatment on cognitive function in postmenopausal women
    Yesufu, Amina
    Bandelow, Stephan
    Hogervorst, Eva
    WOMENS HEALTH, 2007, 3 (02) : 173 - 194
  • [34] Estrogen improves membrane functions of erythrocytes in hypertensive postmenopausal women via a nitric oxide-dependent mechanism
    Tsuda, K
    Kimura, K
    Mabuchi, Y
    Kinoshita-Shimamoto, Y
    Nishio, I
    CIRCULATION, 2002, 106 (19) : 112 - 112
  • [35] Intranasal cerebrolysin improves cognitive function and structural synaptic plasticity in photothrombotic mouse model of medial prefrontal cortex ischemia
    Sadigh-Eteghad, Saeed
    Geranmayeh, Mohammad Hossein
    Majdi, Alireza
    Salehpour, Farzad
    Mahmoudi, Javad
    Farhoudi, Mehdi
    NEUROPEPTIDES, 2018, 71 : 61 - 69
  • [36] Estrogen treatment improves arterial distensibility, fibrinolysis, and metabolic profile in postmenopausal women with type 2 diabetes mellitus
    Sztejnsznajd, Claudia
    Rossi da Silva, Maria Elizabeth
    Nussbacher, Amit
    Gebara, Otavio Eluf
    D'Amico, Elbio Antonio
    Rocha, Dalva Marriero
    Flores da Rocha, Tania Rubia
    dos Santos, Rosa Ferreira
    Wajngarten, Mauricio
    Fukui, Rosa Tesumechiro
    Soares Correia, Marcia Regina
    Wajchenberg, Bernardo Leo
    Maria Ursich, Mileni Josefina
    METABOLISM-CLINICAL AND EXPERIMENTAL, 2006, 55 (07): : 953 - 959
  • [37] Raloxifene hydrochloride, a selective estrogen receptor modulator: safety assessment of effects on cognitive function and mood in postmenopausal women
    Nickelsen, T
    Lufkin, EG
    Riggs, BL
    Cox, DA
    Crook, TH
    PSYCHONEUROENDOCRINOLOGY, 1999, 24 (01) : 115 - 128
  • [38] Endogenous and Exogenous Estrogen, Cognitive Function, and Dementia in Postmenopausal Women: Evidence from Epidemiologic Studies and Clinical Trials
    Barrett-Connor, Elizabeth
    Laughlin, Gail A.
    SEMINARS IN REPRODUCTIVE MEDICINE, 2009, 27 (03) : 275 - 282
  • [39] Hormone replacement therapy but not selective estrogen receptor modulators improves endothelial function in postmenopausal women at increased cardiovascular risk
    Rosano, G
    Cerquetani, E
    Mercuro, G
    Fini, M
    Zoncu, S
    Onorati, D
    Vitale, C
    Pizzo, F
    EUROPEAN HEART JOURNAL, 2001, 22 : 164 - 164
  • [40] Evaluation of high-dose estrogen and high-dose estrogen plus methyltestosterone treatment on cognitive task performance in postmenopausal women
    Wisniewski, AB
    Nguyen, TT
    Dobs, AS
    HORMONE RESEARCH, 2002, 58 (03) : 150 - 155